Mao Q - Search Results

1

Baseline hepatitis B core antibody predicts treatment response in chronic hepatitis B patients receiving long-term entecavir.

Xu JH, Song LW, Li N, Wang S, Zeng Z, Si CW, Li J, Mao Q, Zhang DZ, Tang H, Sheng JF, Chen XY, Ning Q, Shi GF, Xie Q, Yuan Q, Yu YY, Xia NS. Xu JH, et al. Among authors: mao q. J Viral Hepat. 2017 Feb;24(2):148-154. doi: 10.1111/jvh.12626. Epub 2016 Nov 28. J Viral Hepat. 2017. PMID: 27891715 Clinical Trial.

2

[Inhibition of genomic HDV ribozyme activity by antisense oligodeoxynucleotides].

Mao Q, Wang S, Li Q. Mao Q, et al. Zhonghua Yi Xue Za Zhi. 1996 Jan;76(1):30-3. Zhonghua Yi Xue Za Zhi. 1996. PMID: 8758460 Chinese.

3

[Reconstruction of hepatitis D virus ribozymes and their ability to trans-cleave hepatitis C virus RNA].

Yu Y, Mao Q, Li Q, Wang Y, Min F. Yu Y, et al. Among authors: mao q. Zhonghua Gan Zang Bing Za Zhi. 2001 Jun;9(3):157-9. Zhonghua Gan Zang Bing Za Zhi. 2001. PMID: 11412391 Chinese.

4

[Clinical significance of neutralizing anti-interferon antibodies in chronic hepatitis B patients treated with recombinant interferon-alpha].

Mao QG, Luo KX, Liu DL, Zhang MX, Hou JL. Mao QG, et al. Zhonghua Gan Zang Bing Za Zhi. 2004 Apr;12(4):205-7. Zhonghua Gan Zang Bing Za Zhi. 2004. PMID: 15099466 Chinese.

5

[A study of the causes of poor antiviral responses in male chronic hepatitis B patients treated with recombinant interferon-alpha].

Mao QG, Liu DL, Zhang MX, Feng XR, Hou JL. Mao QG, et al. Zhonghua Gan Zang Bing Za Zhi. 2005 Jan;13(1):24-6. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 15670486 Chinese.

6

No significant differences in histology and response to interferon treatment in hepatitis B carriers of genotypes C and recombinant B.

Luo K, He H, Liu Z, Zhu Y, Mao Q, Liang W. Luo K, et al. Among authors: mao q. J Viral Hepat. 2007 Jun;14(6):419-25. doi: 10.1111/j.1365-2893.2006.00825.x. J Viral Hepat. 2007. PMID: 17501763 Clinical Trial.

7

Tailored regimen of interferon alpha for HBeAg-positive chronic hepatitis B: a prospective controlled study.

Luo K, Mao Q, Karayiannis P, Liu D, Liu Z, Zhou Y, Feng X, Zhu Y, Guo Y, Jiang R, Zhou F, Peng J, Hou J. Luo K, et al. Among authors: mao q. J Viral Hepat. 2008 Sep;15(9):684-9. doi: 10.1111/j.1365-2893.2008.00995.x. Epub 2008 Jun 28. J Viral Hepat. 2008. PMID: 18554243 Clinical Trial.

8

Regulatory polymorphisms in the IL-10 gene promoter and HBV-related acute liver failure in the Chinese population.

Yan Z, Tan W, Zhao W, Dan Y, Wang X, Mao Q, Wang Y, Deng G. Yan Z, et al. Among authors: mao q. J Viral Hepat. 2009 Nov;16(11):775-83. doi: 10.1111/j.1365-2893.2009.01139.x. Epub 2009 Apr 27. J Viral Hepat. 2009. PMID: 19413695

9

Human hepatoma HepaRG cell line engraftment in severe combined immunodeficient × beige mice using mouse-specific anti-Fas antibody.

Jiang L, Li JG, Lan L, Wang YM, Mao Q, You JP. Jiang L, et al. Among authors: mao q. Transplant Proc. 2010 Nov;42(9):3773-8. doi: 10.1016/j.transproceed.2010.08.064. Transplant Proc. 2010. PMID: 21094855

10

Twenty-four weeks of pegylated interferon plus ribavirin effectively treat patients with HCV genotype 6a.

Zhou YQ, Wang XH, Hong GH, Zhu Y, Zhang XQ, Hu YJ, Mao Q. Zhou YQ, et al. Among authors: mao q. J Viral Hepat. 2011 Aug;18(8):595-600. doi: 10.1111/j.1365-2893.2010.01373.x. Epub 2010 Nov 24. J Viral Hepat. 2011. PMID: 21105968

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,223 results

Search Page

Filters